<DOC>
	<DOC>NCT00562653</DOC>
	<brief_summary>The purpose is to evaluate autoantibodies in infective endocarditis patients before, at the beginning of treatment, and after the end of the treatment, and to correlate the autoantibodies in the presence of clinical symptoms.</brief_summary>
	<brief_title>Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients</brief_title>
	<detailed_description />
	<mesh_term>Endocarditis</mesh_term>
	<mesh_term>Endocarditis, Bacterial</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Infective endocarditis patients by DUKES criteria HIV positive Patients suffering from other infective diseases other than endocarditis. Patient suffering from collagen diseases for example: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), mixed connective tissue disease, and scleroderma.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>profile autoantibodies</keyword>
	<keyword>clinical symptoms</keyword>
</DOC>